A current perspective on the pathological assessment of FOXL2 in adult-type granulosa cell tumours of the ovary

Histopathology

Volumn 64, Issue 3, 2014, Pages 380-388

  Kommoss, Stefan ^a,b   Gilks, Cyril Blake ^b   Penzel, Roland ^c   Herpel, Esther ^c   Mackenzie, Robertson ^d   Huntsman, David ^b,d   Schirmacher, Peter ^c   Anglesio, Michael ^b   Schmidt, Dietmar ^e   Kommoss, Friedrich ^e  

^a UNIVERSITY OF TÜBINGEN   (Germany)

^b UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^c UNIVERSITY OF HEIDELBERG   (Germany)

^d Centre for Translational and Applied Genomics   (Canada)

^e Institute of Pathology   (Germany)

Author keywords

Adult type granulosa cell tumour; FOXL2 mutation; Immunohistochemistry; Molecular diagnostics; Ovary

Indexed keywords

FORKHEAD BOX PROTEIN L2; FORKHEAD TRANSCRIPTION FACTOR; UNCLASSIFIED DRUG;

ARTICLE; CONTROLLED STUDY; DIFFERENTIATION; FEMALE; GENE MUTATION; GRANULOSA CELL TUMOR; HISTOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; SINGLE BLIND PROCEDURE;

ADULT-TYPE GRANULOSA CELL TUMOUR; FOXL2 MUTATION; IMMUNOHISTOCHEMISTRY; MOLECULAR DIAGNOSTICS; OVARY;

ADULT; COHORT STUDIES; DNA MUTATIONAL ANALYSIS; DNA, NEOPLASM; FEMALE; FORKHEAD TRANSCRIPTION FACTORS; GRANULOSA CELL TUMOR; HUMANS; IMMUNOHISTOCHEMISTRY; MUTANT PROTEINS; OVARIAN NEOPLASMS; POINT MUTATION; RETROSPECTIVE STUDIES; TUMOR MARKERS, BIOLOGICAL;

EID: 84892441690     PISSN: 03090167     EISSN: 13652559     Source Type: Journal    
DOI: 10.1111/his.12253     Document Type: Article

References (14)

1. Tavassoli FA, Devilee P. Pathology and genetics of tumours of the breast and female genital organs. Lyon: IARC Press, 2003.
2. Shah SP, Kobel M, Senz J et al. Mutation of FOXL2 in granulosa-cell tumors of the ovary. N. Engl. J. Med. 2009; 360; 2719-2729.
3. Björkholm E, Silfversward C. Prognostic factors in granulosa-cell tumors. Gynecol. Oncol. 1981; 11; 261-274.
4. Malmström H, Hogberg T, Risberg B, Simonsen E. Granulosa cell tumors of the ovary: prognostic factors and outcome. Gynecol. Oncol. 1994; 52; 50-55.
5. Schumer ST, Cannistra SA. Granulosa cell tumor of the ovary. J. Clin. Oncol. 2003; 21; 1180-1189.
6. Nofech-Mozes S, Ismiil N, Dube V et al. Immunohistochemical characterization of primary and recurrent adult granulosa cell tumors. Int. J. Gynecol. Pathol. 2012; 31; 80-90.
7. Zhao C, Vinh TN, McManus K, Dabbs D, Barner R, Vang R. Identification of the most sensitive and robust immunohistochemical markers in different categories of ovarian sex cord-stromal tumors. Am. J. Surg. Pathol. 2009; 33; 354-366.
8. McCluggage WG, Young RH. Immunohistochemistry as a diagnostic aid in the evaluation of ovarian tumors. Semin. Diagn. Pathol. 2005; 22; 3-32.
9. Kommoss F, Schmidt D. Immunohistochemical sex cord markers. Description and use in the differential diagnosis of ovarian tumors. Pathologe 2007; 28; 187-194.
10. Al-Agha OM, Huwait HF, Chow C et al. FOXL2 is a sensitive and specific marker for sex cord-stromal tumors of the ovary. Am. J. Surg. Pathol. 2011; 35; 484-494.
11. Kommoss S, Anglesio MS, Mackenzie R et al. FOXL2 molecular testing in ovarian neoplasms: diagnostic approach and procedural guidelines. Mod. Pathol. 2013; 26; 860-867.
12. Oliva E, Garcia-Miralles N, Vu Q, Young RH. CD10 expression in pure stromal and sex cord-stromal tumors of the ovary: an immunohistochemical analysis of 101 cases. Int. J. Gynecol. Pathol. 2007; 26; 359-367.
13. Aguirre P, Thor AD, Scully RE. Ovarian endometrioid carcinomas resembling sex cord-stromal tumors. An immunohistochemical study. Int. J. Gynecol. Pathol. 1989; 8; 364-373.
14. Schrader KA, Gorbatcheva B, Senz J et al. The specificity of the FOXL2 c.402C>G somatic mutation: a survey of solid tumors. PLoS ONE 2009; 4; e7988.